Mounjaro becomes the first GIP/GLP-1 receptor agonist cleared to lower MACE risk, based on the SURPASS-CVOT head-to-head trial.
|Articles|May 1, 2008
- Volume 0 0
advertiserINDEX
Advertisement
Articles in this issue
over 18 years ago
productHOTLINEover 18 years ago
Motion Sickness: Calming the Waves of Upsetover 18 years ago
pharmacy Pet Peevesover 18 years ago
recruitment/RESOURCESover 18 years ago
canyouREADtheseRxs?over 18 years ago
Case Studiesover 18 years ago
DIABETESWATCHover 18 years ago
CHOLESTEROLWATCHover 18 years ago
compoundingHOTLINEover 18 years ago
ARTHRITISWATCHAdvertisement
Related to this article
Two recent graduates share strategies for standing out in the competitive fellowship application process.
Community pharmacies are access points, safe places, and sources of stability when everything else feels uncertain.
Impostor syndrome prevalence in oncology pharmacists is a complex topic that is not well described.
This quiz was created in collaboration with PTCE™.
Pharmacy professionals can leverage LinkedIn to build a professional brand, expand meaningful connections, share expertise, and create opportunities for career growth.
An Italian pharmacy student offers an inside look at pharmacy education in Italy, from admission and coursework to oral exams and professional training.
Pharmacy students can create greater career optionality by viewing the PharmD as a professional platform rather than a predetermined job title.
Advertisement
Advertisement